Literature DB >> 1769441

The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus.

D Ziegler1, P Mayer, H Mühlen, F A Gries.   

Abstract

The natural evolution of neural dysfunction was studied prospectively over 5 years following diagnosis of Type 1 (insulin-dependent) diabetes in 32 patients aged 12-36 years. Motor and sensory nerve conduction velocities, heart rate variation at rest and during deep breathing, and pupillary function were measured at diagnosis and after 3, 12, 24, 48, and 60 months. Thermal and vibration sensation thresholds were determined after 24, 48, and 60 months of diabetes. Mean HbA1 levels of months 3-60 within the normal range of less than 8.3% (7.3 +/- 0.2%) were observed in 13 patients (Group 1), while a mean HbA1 of months 3-60 greater than or equal to 8.3% (10.0 +/- 0.3%) was found in 19 patients (Group 2). Mean nerve conduction was significantly diminished in Group 2 as compared with Group 1 in at least 4 out of 6 nerves tested during months 12-60 (p less than 0.05). Both tests of heart rate variation were significantly impaired in Group 2 as compared with Group 1 after 24 and 60 months (p less than 0.05), but no differences in pupillary function were observed between the groups. Thermal discrimination but not vibration perception thresholds on the foot were significantly higher in Group 2 than in Group 1 at 40 and 60 months (p less than 0.05). Abnormalities in nerve conduction, thermal discrimination, and heart rate variation, but not vibration perception threshold and the pupillary function tests were significantly more frequent in Group 2 than in Group 1 at 60 months (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769441     DOI: 10.1007/bf00408358

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Cigarette smoking and neuropathy in diabetic patients.

Authors:  B D Mitchell; V M Hawthorne; A I Vinik
Journal:  Diabetes Care       Date:  1990-04       Impact factor: 19.112

2.  Improvement in nerve conduction following treatment in newly diagnosed diabetics.

Authors:  J D Ward; C G Barnes; D J Fisher; J D Jessop; R W Baker
Journal:  Lancet       Date:  1971-02-27       Impact factor: 79.321

3.  Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients.

Authors:  G Gregersen
Journal:  Diabetologia       Date:  1968-11       Impact factor: 10.122

4.  Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.

Authors:  D Ziegler; K Wiefels; K Dannehl; F A Gries
Journal:  Klin Wochenschr       Date:  1988-05-02

5.  Peripheral and autonomic nerve function in long-term insulin-dependent diabetes.

Authors:  D Ziegler; I Cicmir; K Wiefels; H Berger; F A Gries
Journal:  Diabetes Res       Date:  1987-01

6.  Diabetic neuropathy and plasma glucose control.

Authors:  D Porte; R J Graf; J B Halter; M A Pfeifer; E Halar
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

7.  Microcomputer-based measurement of beat-to-beat intervals and analysis of heart rate variability.

Authors:  A Morguet; H J Springer
Journal:  Med Prog Technol       Date:  1981

8.  Method for quantitative estimation of thermal thresholds in patients.

Authors:  H Fruhstorfer; U Lindblom; W C Schmidt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

9.  The effect of strict short-term metabolic control on retinal nervous system abnormalities in newly diagnosed Type 1 (insulin-dependent) diabetic patients.

Authors:  K Frost-Larsen; J S Christiansen; H H Parving
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

10.  Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy.

Authors:  P J Dyck; J L Karnes; J Daube; P O'Brien; F J Service
Journal:  Brain       Date:  1985-12       Impact factor: 13.501

View more
  17 in total

1.  Neurophysiological tests in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients with subclinical and symptomatic neuropathy.

Authors:  D Ziegler; H Mühlen; F A Gries
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

2.  Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).

Authors:  D Ziegler; M Hanefeld; K J Ruhnau; H P Meissner; M Lobisch; K Schütte; F A Gries
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

3.  Cardiac autonomic function in children with type 1 diabetes.

Authors:  Kotb Abbass Metwalley; Sherifa Ahmed Hamed; Hekma Saad Farghaly
Journal:  Eur J Pediatr       Date:  2018-03-02       Impact factor: 3.183

Review 4.  Glucose control and diabetic neuropathy: lessons from recent large clinical trials.

Authors:  Lynn Ang; Mamta Jaiswal; Catherine Martin; Rodica Pop-Busui
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 5.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

6.  [13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function.

Authors:  D Ziegler; P Schadewaldt; A Pour Mirza; R Piolot; B Schommartz; M Reinhardt; H Vosberg; H Brösicke; F A Gries
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

7.  The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.

Authors:  N E Cameron; M A Cotter; K C Dines; S Robertson; D Cox
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study.

Authors: 
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

Review 9.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

10.  Subclinical nerve dysfunction in children and adolescents with IDDM.

Authors:  L Hyllienmark; T Brismar; J Ludvigsson
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.